1 – 13 of 13
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Anxiety and depression among women with newly diagnosed vulvar cancer – A nationwide longitudinal study
(
- Contribution to journal › Article
-
Mark
Has time to chemotherapy from primary debulking surgery in advanced ovarian cancer an impact on survival? - A population-based nationwide SweGCG study
(
- Contribution to journal › Article
- 2022
-
Mark
Long-term incidence of endometrial cancer after endometrial resection and ablation : A population based Swedish gynecologic cancer group (SweGCG) study
(
- Contribution to journal › Article
-
Mark
The wait time to primary surgery in endometrial cancer–impact on survival and predictive factors : a population-based SweGCG study
(
- Contribution to journal › Article
- 2021
-
Mark
Survival in endometrial cancer in relation to minimally invasive surgery or open surgery – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
-
Mark
Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study
(
- Contribution to journal › Article
- 2020
-
Mark
Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma : A population-based SweGCG study
(
- Contribution to journal › Article
- 2019
-
Mark
Can we extend the indication for sentinel node biopsy in vulvar cancer? A nationwide feasibility study from Sweden
2019) In International Journal of Gynecological Cancer(
- Contribution to journal › Article
-
Mark
Primary treatment patterns and survival of cervical cancer in Sweden : A population-based Swedish Gynecologic Cancer Group Study
(
- Contribution to journal › Article
-
Mark
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
- 2018
-
Mark
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
-
Mark
Data quality in the Swedish Quality Register of Gynecologic Cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
(
- Contribution to journal › Article
- 2017
-
Mark
Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)
(
- Contribution to journal › Article